Webinar | Women’s Nutrition: Nourishing Womanhood From Pregnancy To Menopause
11 September | 12 PM ET: Register Now

Panaxium

Panaxium is a bioelectronic medicine company that develops AI-enabled iontronic devices for neurological diseases
2016
Nov-50
11-50
Aix-en-Provence, France
  • Healthcare
  • Medical Imaging and Visualization Technology
  • Personalized Medicine Technologies

Innovation

Industry Problem

Neurological disorders need thin, conformable interfaces that stimulate tissue precisely without bulky conventional implants.

R&D Focus

Iontronic neurostimulation, flexible bioelectronics and AI-guided therapy.

Innovative Solution

Uses ultrathin iontronic devices that deliver ionic stimulation through conformable interfaces placed near neural tissue.

Investment Funding

Last Funding Stage

Seed

Total Funding Amount

$13.3M

Last Funding Amount

$5M

Last Funding Date

04-10-2023

Startup Stage

Early Stage

Lead Investors

Blueriver Capital, Ontario Brain Institute, Creative Destruction Lab, Incubateur Impulse

People

Founders

CEO

About

Panaxium is a bioelectronic medicine company that develops AI-enabled iontronic devices for neurological diseases

Products

Product

NeuroGrid iontronic stimulation platform.

Star Product

NeuroGrid, because it is the lead ultrathin neural-interface platform.

Demo Product or Complete Product?

Preclinical and translational development stage.

M&A and Collabs

Collab

Synaptive Medical: collaboration on surgical integration and neurotechnology development.

Collab

Ontario Brain Institute: investment and ecosystem support.

Something missing or incorrect on this page? Help us enrich this information